PwC named a Leader in the IDC MarketScape: Worldwide Life Science R&D Strategic Consulting Services

January 12, 2024

PwC has been named a Leader in the IDC MarketScape: Worldwide Life Science R&D Strategic Consulting Services 2023 Vendor Assessment (December 2023, IDC #US49950023). 

‘The life sciences industry is struggling to reach a steady state. It has undergone wave after wave of disruption, owing to the COVID-19 pandemic, the evolving geopolitical scenario, and now, by generative AI.’

Commenting on PwC, the IDC MarketScape report states, ‘PwC brings deep, life sciences industry-specific expertise to engagements to focus on value creation and drive business transformation, design portfolio strategy, and innovation by leveraging its advisory services and digital assets. It improves patient outcomes and engagement through digital technologies and decentralized trials, drives productivity gains, shortens clinical trial execution timelines by optimizing clinical trial design, and improves engagement across the healthcare ecosystem.’

On PwC’s strengths, the report says, ‘Its key differentiators include its integrated transformation, cloud, digital, and managed services crossplatform strategy focused on innovation, its multidisciplinary team, which provides a unified approach across business process analysis and design, software development life cycle (SDLC) documentation and testing, and change management and training, and last, its expertise in ICH E6-compliant vendor oversight, quality management, and quality by design.’ 

It goes on to say, ‘Consider PwC when seeking a strategic consulting (SC) partner with deep expertise in M&A strategy, management consulting, change management, role transformation, process optimization, pricing and market access strategy, data integration and digital health strategy, and cyber, risk and compliance expertise. PwC's strength lies in its integrated multidisciplinary team, in-depth transformation strategy, and managed services capabilities, wrapped up by a pragmatic and innovative strategy that it brings to the table.’


IDC ESG/Sustainability Strategy 2023

IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

‘We are pleased to be named a Leader in this IDC MarketScape. Now more than ever, Life Sciences companies are under intense pressure to introduce new products in an environment of escalating R&D costs, complex science, heightened regulatory scrutiny, and increased competition. With end-to-end capabilities—from discovery through product life cycle management—PwC’s R&D team engages across functions to help enable more seamless business operations and helps organizations offer increased benefits and value to patients while streamlining their processes.’

Glenn Hunzinger, Partner and US Pharmaceutical & Life Sciences Consulting Solutions Leader, PwC US

Contact us

Rob Donnelly

Global Analyst & Advisor Relations Leader, PwC United States

Tel: +1 (917) 471 3355

Follow us